Helle Kristine Skjerven

Years Active: 2024-2024
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Kamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, Sameer Bhargava, Andliena Tahiri, Jovana Klajic, Torben Lüders, Marie Fongård, Meh Sameen Nawaz, Tatjana Bosnjak-Olsen, Unn-Cathrin Edvardsen Buvarp, Aino Katri Johanna Rosenskiold, Nam Thi Nguyen, Tone Tysko Sletbak, Manouchehr Seyedzadeh, Knut Selsås, Alina Carmen Porojnicu, Helle Kristine Skjerven, Tone Hovda, Kristine Kleivi Sahlberg, Lilly Anne Torland, Marianne Lyngra, Clara Louise Hammarström, Elma Bahonjic Hönigsperger, John Christopher Noone, Silje Mathiassen, Antoni Hurtado, Shom Goel, Andrew Koff, Xavier Tekpli, Vessela N Kristensen, Jürgen Geisler
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer. Future oncology (London, England) (2024)

Helle Kristine Skjerven.css-eqlu8i{font-size:small;padding-left:4px;}